Global Strategic Outlook on the Blood Banking and Blood

Dublin, July 06, 2018 (GLOBE NEWSWIRE) -- The "Blood Banking and Blood Products - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. This report analyzes the worldwide markets in US$ Million by the following Product Group/Types:

• Blood Components and Plasma Products (Whole Blood & Cellular Components, & Plasma Fractions)
• Equipment
• Blood Tests
• Other Consumables

The report profiles 209 companies including many key and niche players such as:

• AABB (USA)
• America's Blood Centers (USA)
• American Red Cross (USA)
• Canadian Blood Services (Canada)
• Japan Red Cross Society (Japan)
• New York Blood Center (USA)
• Sanquin Blood Supply Foundation (The Netherlands)
• Abbott Laboratories (USA)
• Beckman Coulter, Inc. (USA)
• Becton, Dickinson and Company (USA)
• bioMrieux SA (France)
• Bio-Rad Laboratories, Inc. (USA)
• Cerus Corporation (USA)
• CSL Behring LLC (USA)
• Fresenius Kabi AG (Germany)
• Fenwal Inc. (USA)
• Haemonetics Corporation (USA)
• Immucor Inc. (USA)
• Kawasumi Laboratories, Inc. (Japan)
• Ortho-Clinical Diagnostics, Inc. (USA)
• Terumo BCT Inc. (USA)
• Leading Players in Plasma Fractionation
• Beijing Tiantan Biological Products Co., Ltd. (China)
• Bharat Serums and Vaccines Ltd. (India)
• Bio Products Laboratory Ltd. (UK)
• Biotest AG (Germany)
• China Biologic Products, Inc. (China)
• Grifols S.A. (Spain)
• Huanlan Biological Engineering Inc. (China)
• Kedrion S.p.A. (Italy)
• LFB Group (France)
• Octapharma AG (Switzerland)
• Shanghai RAAS Blood Products Co., Ltd. (China)
• Shire plc (Ireland)
• Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. (China)

Key Topics Covered

1. MARKET OVERVIEW Prelude Blood Transfusion Worldwide: A Kaleidoscope of Stark Contrasts Safety and Availability: The Core Issues Current and Future Analysis Analysis of World Blood Banking & Blood Products by Value Sales World Blood Components and Plasma Market Analysis Red Blood Cells A Key Blood Component 2. MARKET TRENDS & ISSUES Blood Plasma Demand Exceeds Supply: Self-Sufficiency is the New Mantra Higher Plasma Center Numbers Key to Secure Raw Material Supply, Costs Remain A Bottleneck Platelet Rich Plasma Therapy Market Scales New Heights Evolution in Plasma Collection Technologies Current Achievements and Way Ahead Demand for Plasma Derivatives on the Rise Immunoglobulins to See Steady Growth Increasing Awareness of PID and CIPD Disorders to Drive IVIg Market Indications Addressed by Major Global IVIg Manufacturers Growing Affinity for Home Care Unlocks Opportunities for Home-based IVIg Therapy Unsuccessful Clinical Trials for Alzheimer's a major Setback for IVIg Market New Indications to Drive Demand for Albumin Low Awareness Affects Apha1 Market Recombinants Lead FVIII Market Rising Incidence of Cancer Drives Demand for Apheresis Systems PrIME: An Innovative High-Yield Process to Address Supply Dearth Present State of Plasma Fractionating Industry Plasma Fractionation Industry Concentrated in Developed Countries PrIME Tackles the Issue of Currently Unprocessable Plasma Industry Grappling with Blood Safety & Availability Issues New Infections A Continuous Threat Synthetic Substitutes to Bridge Demand-Supply Gap in Blood Autologous Transfusion Gearing up for High Growth Out-of-Hospital Transfusions: An Emerging Phenomenon Automation Tapping into Blood Market Automation in Pre-Transfusion Diagnostics Penetration of Automated Equipment in the Plasma Market The Red Blood Cell Collection Opportunity Robots in Blood Banking Automated Blood Processing Systems in Open Heart Surgeries Automated Systems in Cancer Cerus' INTERCEPT Blood System Set to See Wider Adoption Pooling: Economical HIV Testing Ballooning Global Geriatric Populace to Drive Demand for Blood Products Improving Healthcare Expenditure to Foster Growth of Blood Banking Sector 3. COMPETITIVE LANDSCAPE Leaders in Global Blood Plasma Ramp Up Market Share Grifols A Fast Emerging Player Grifols Loses Grip on IG Market, Pins Hopes on New Product IVIg A Highly Consolidated Market Big Three Corner Majority of Blood Collection Systems Market Other Key Statistics 4. PRODUCT OVERVIEW 5. BLOOD COLLECTION METHODS Banking the Natural Blood Resources Blood Banks Blood Banking Blood Transfusion Role of Blood Banks Blood Donor: The Epicenter of the Process Eligibility Criteria for the Donor The Basics of Blood Donation Myths & Facts Collection Methods Blood Donation: The Process Blood Salvaging Blood Collection Centers Blood Processing The Costs History of Blood Banking 6. THE DYNAMIC LANDSCAPE OF TRANSFUSION TECHNOLOGIES & TESTS Blood Transfusion: A Backdrop Massive Transfusion Complications and Risks Due to Transfusion Circulatory Overload Graft Versus Host Disease (GVHD) Hemolytic Transfusion Reactions Iron Overload Bacterial Contamination Thrombophlebitis Allergic Reactions Air Embolism Hyperkalaemia Changing Role of Blood Banking Technology 7. BLOOD TRANSFUSION: THE PROCESS, TESTS/TECHNOLOGIES Cross Matching Blood Donor/Recipient Screening Blood Typing Leukoreduction Leukocyte Reduction Specification Standards/Filters Coombs Test 8. ALTERNATIVES TO BLOOD TRANSFUSION: A REAL THREAT TO THE INDUSTRY Bloodless Surgery Therapeutic Apheresis Plasmapheresis Plateletpheresis Leukapheresis Volume Expanders Colloids Crystalloids Blood Growth Factor Therapies Newer Alternatives to Transfusion 9. PRODUCT APPROVALS/LAUNCHES Biotest Secures EC Clearance for Vihuma Roche Launches cobas m 511 Haematology Analyser Abbott Obtains CE Mark for Alinity s Blood and Plasma Screening Device Bio-Rad Secures FDA Clearance for New Blood Typing Instrument and Regents Immucor Gets CE Mark for NEO Iris Automated Transfusion Instrument Immucor's PreciseType HEA Test Obtains FDA Approval Fresenius Kabi Obtains FDA Approval for Aurora Xi Plasmapheresis System BD Secures FDA Clearance for BD Barricor Plasma Blood Collection Tube Cerus Gains Health Canada's Approval for INTERCEPT System FDA Clears BD's New Plastic Blood Culture Bottle FDA Approves Cerus' INTERCEPT Blood System BD Obtains CE Mark for Vacutainer Barricor Tube BD Secures FDA and EU Clearance for BD Vacutainer UltraTouch Blood Collection Set Roche Expands Blood Screening Solution Portfolio with New Offering Roche Receives USFDA Approval for cobas TaqScreen MPX Test v2 .0 for HIV, HCV, and HBV Tests Affinity Biologicals Unveils Factor VIII Deficient, Factor IX Deficient Plasmas 10. RECENT INDUSTRY ACTIVITY Biotest to Sell Select US Therapy Business Assets to ADMA Kedrion Biopharma Expands into Russia Hologic to Sell Blood Screening Business to Grifols China Biologic Products Gets CFDA Clearance for Antithrombin III Clinical Trial China Biologic Receives CFDA Clearance for Human Trials on Human Coagulation Factor IX Terumo Inks Distribution Agreement with B Medical Systems Creat Group Takes Over Bio Products Terumo Receives Initial Funding for FDP Product from US Government Shire Takes Over Baxalta LFB American Plasma and ImmunoTek BioCenters Ink Agreement Grifols Expands Plasma Therapies' Production Capacity KEDPlasma Acquires Two Plasma Collection Centers in the US Cerus and LifeShare Blood Centers Ink Purchase Agreement for INTERCEPT Cerus Inks Production Deal with Fresenius Kabi for INTERCEPT Blood System Baxter Spins Off Biopharmaceutical Business into Baxalta (US) Cerus and SunCoast Blood Bank Ink Deal for INTERCEPT Blood System Cerus Corporation Inks Purchase Agreement with Karolinska University Hospital Cerus Corporation Signs Purchase Agreement with Blood Bank of Delmarva Canadian Blood Services Closes 3 Permanent Clinics, Terminates Bloodmobile Program Roche Releases Elecsys HTLV-I/II Immunoassay China Biologic Products Purchases Additional Stake in Guizhou Taibang Biological Products Community Blood Center Merges with New York Blood Center Cerus Corp. Partners with Kawasumi Laboratories for Developing Intercept Platelets Kits Vascular Solutions Collaborates with US AMMDA to Develop Plasma Products for Treating Hemorrhage The San Diego Blood Bank Collaborates with Clinical and Translational Research Institute AABB Collaborates with AATM for Promoting Blood and Cellular Therapies Standards in Asia bioCSL Partners with Immucor for Distributing Transfusion Technology in Australia and New Zealand PrIME Biologics Opens Plasma Fractionation Plant in Singapore 11. FOCUS ON SELECT PLAYERS Leading Blood Banks AABB (USA) America's Blood Centers (USA) American Red Cross (USA) Canadian Blood Services (Canada) Japan Red Cross Society (Japan) New York Blood Center (USA) Sanquin Blood Supply Foundation (The Netherlands) Leading Players in Blood Bank Technology and Supplies Abbott Laboratories (USA) Beckman Coulter, Inc. (USA) Becton, Dickinson and Company (USA) bioMrieux SA (France) Bio-Rad Laboratories, Inc. (USA) Cerus Corporation (USA) CSL Behring LLC (USA) Fresenius Kabi AG (Germany) Fenwal Inc. (USA) Haemonetics Corporation (USA) Immucor Inc. (USA) Kawasumi Laboratories, Inc. (Japan) MacoPharma SA (France) Ortho-Clinical Diagnostics, Inc. (USA) Terumo BCT Inc. (USA) Leading Players in Plasma Fractionation Beijing Tiantan Biological Products Co., Ltd. (China) Bharat Serums and Vaccines Ltd. (India) Bio Products Laboratory Ltd. (UK) Biotest AG (Germany) China Biologic Products, Inc. (China) Grifols S.A. (Spain) Huanlan Biological Engineering Inc. (China) Kedrion S.p.A. (Italy) LFB Group (France) Octapharma AG (Switzerland) Shanghai RAAS Blood Products Co., Ltd. (China) Shire plc (Ireland) Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. (China) 12. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled: 209 (including Divisions/Subsidiaries 253)

• The United States (117)
• Canada (10)
• Japan (12)
• Europe (51)
  • France (4)
  • Germany (13)
  • The United Kingdom (11)
  • Italy (4)
  • Spain (3)
  • Rest of Europe (16)
• Asia-Pacific (Excluding Japan) (59)
• Middle East (1)
• Latin America (1)
• Africa (2)

For more information about this report visit https://www.researchandmarkets.com/research/t...tegic?w=12

CONTACT: ResearchAndMarkets.com Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Blood Banking